Elicio Therapeutics Inc.

Contributing Author

Recent Articles by Elicio Therapeutics Inc.

Jun-17	Elicio Therapeutics to Host Virtual KOL Event on June 25, 2025 to Discuss AMP-Powered ELI-002 for the Treatment of KRAS mutation-driven Pancreatic Cancer ELTX GlobeNewswire
Jun-04	Elicio Therapeutics Secures $10 Million in Financing ELTX GlobeNewswire
May-13	Elicio Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Updates ELTX GlobeNewswire